EYPT FY 2018 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

EYPTEyePoint Pharmaceuticals, Inc.

$1B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-60.7% YoY

Gross Profit

-$16M-524.9% margin

Operating Income

-$26M-887.3% margin

Net Income

-$53M-1795.7% margin

EPS (Diluted)

$-11.50

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$22M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$72M

Total Liabilities

$60M

Stockholders' Equity

$12M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$8M	-60.7%
Gross Profit	-$16M	$8M	-306.1%
Operating Income	-$26M	-$19M	-41.4%
Net Income	-$53M	-$18M	-187.6%